Adefovir-induced Fanconi syndrome associated with osteomalacia

Clin Mol Hepatol. 2018 Sep;24(3):339-344. doi: 10.3350/cmh.2017.0009. Epub 2017 Sep 1.

Abstract

Fanconi syndrome is a dysfunction of the proximal renal tubules that results in impaired reabsorption and increased urinary loss of phosphate and other solutes. The pathophysiology of drug-induced Fanconi syndrome is unclear. Here we report the case of a 36-year-old woman who presented with pain in multiple bones and proteinuria. She had a 7-year history of taking adefovir at 10 mg/day for chronic hepatitis B. Three years previously she had received surgery for a nontraumatic right femur neck fracture, after which she continued to complain of pain in multiple bones, and proteinuria, glycosuria, and phosphaturia were noted. The findings of a light-microscope examination of a renal biopsy sample were normal, but mitochondrial damage of the proximal tubules was evident in electron microscopy. Western blot analysis revealed that the level of serum fibroblast growth factor 23 (FGF23) was lower than in normal controls. After 2 months of treatment, hypophosphatemia and proximal tubular dysfunction were reversed, and serum FGF23 had normalized. This case suggests that direct mitochondrial damage in proximal tubules can cause drug-induced Fanconi syndrome associated with osteomalacia.

Keywords: Adefovir; Fanconi syndrome; Mitochondria; Osteomalacia; Proximal tubules.

Publication types

  • Case Reports

MeSH terms

  • Adenine / adverse effects
  • Adenine / analogs & derivatives*
  • Adenine / therapeutic use
  • Adenine / toxicity
  • Adult
  • Bone and Bones / drug effects
  • Fanconi Syndrome / diagnosis*
  • Fanconi Syndrome / etiology
  • Female
  • Fibroblast Growth Factor-23
  • Fibroblast Growth Factors / blood
  • Hepatitis B / drug therapy
  • Humans
  • Hypophosphatemia / etiology
  • Hypophosphatemia / pathology
  • Kidney Tubules, Proximal / pathology
  • Mitochondria / drug effects
  • Mitochondria / pathology
  • Organophosphonates / adverse effects*
  • Organophosphonates / therapeutic use
  • Organophosphonates / toxicity
  • Osteomalacia / diagnosis*
  • Osteomalacia / etiology

Substances

  • FGF23 protein, human
  • Organophosphonates
  • Fibroblast Growth Factors
  • adefovir
  • Fibroblast Growth Factor-23
  • Adenine